Dirk Spormann

Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

Jay N. Cohn, Gianni Tognoni, Robert Glazer et al. · Journal of Cardiac Failure · 1999 · 146 citations

Hypertension, Heart Failure, Cardiovascular Disease +9

Valsartan in heart failure patients previously untreated with an ACE inhibitor

V. P. Mazayev, V. A. Sulimov, T.V Zvereva et al. · International Journal of Cardiology · 1998 · 89 citations

Cardiovascular Toxicity, Ace Inhibitor, Heart Failure +11

Biogenesis of the yeast vacuole (lysosome). The precursor forms of the soluble hydrolase carboxypeptidase yscS are associated with the vacuolar membrane.

Dirk Spormann, J. Heim, Detlef Wolf · Journal of Biological Chemistry · 1992 · 59 citations · Full text

Glycobiology, Molecular Biology, Enzymatic Modification +18

Baseline Demographics of the Valsartan Heart Failure Trial

Jay N. Cohn, Gianni Tognoni, Robert Glazer et al. · European Journal of Heart Failure · 2000 · 53 citations · Full text

Carboxypeptidase yscS: gene structure and function of the vacuolar enzyme

Dirk Spormann, Jutta Heim, Dieter H. Wolf · European Journal of Biochemistry · 1991 · 43 citations · Full text

Cloned Cps1 Gene, Cellular Enzymology, Biochemistry +14